Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vietnam Bird Flu Vaccine Could Be On Market By End Of 2009

This article was originally published in PharmAsia News

Executive Summary

A Vietnam-developed vaccine to prevent avian influenza could be on the market in mass-produced quantities by the end of next year. The Company for Vaccine and Biological Production No. 1 said the goal depends on human trials set to begin in Vietnam in late March. The Ministry of Health has cleared human trials of the H5N1 vaccine, but the Ministry of Defense, which would supply students of the Military Medical Academy for the trials, has not yet agreed. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel